Stelios B. Papadopoulos is an entrepreneur and businessperson who founded 6 companies, including: Exelixis, Inc., Anadys Pharmaceuticals, Inc. and Cellzome Ltd. and who has been at the helm of 13 different companies.
He is Chairman at Exelixis, Inc. (which he founded in 1994), Chairman of Eucrates Biomedical Acquisition Corp. (which he founded in 2020), Chairman for Regulus Therapeutics, Inc. and Chairman at Biogen, Inc., Chairman-Supervisory Board of Biogen GmbH (a subsidiary of Biogen, Inc.).
He is also on the board of Diacrin, Inc. (Delaware), Biogen Idec, Inc. (North Carolina) and National Marrow Donor Program and Chairman & Treasurer at Fondation Santé (he founded the company in 2000).
In the past Dr. Papadopoulos held the position of Chief Executive Officer for Merck KGaA, Vice President-Equity Research Department at Drexel Burnham Lambert, Inc., Chairman of PaineWebber Development Corp., Chairman of Anadys Pharmaceuticals, Inc. (he founded the company in 1992), Chairman of Cellzome, Inc. (he founded the company), Chief Executive Officer of CN Biosciences, Inc., President of Instrumentation Laboratory Co., President for Fisher Scientific International, Inc. and Investment Banker at PaineWebber, Inc.
Dr. Papadopoulos received an undergraduate degree from Northrop University and a doctorate, an MBA and a graduate degree from New York University.